Clinical trials
Diabetic Foot trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
184 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 3 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 3 |
| 2009 | 2 |
| 2010 | 4 |
| 2011 | 5 |
| 2012 | 5 |
| 2013 | 7 |
| 2014 | 6 |
| 2015 | 11 |
| 2016 | 8 |
| 2017 | 11 |
| 2018 | 13 |
| 2019 | 17 |
| 2020 | 8 |
| 2021 | 18 |
| 2022 | 21 |
| 2023 | 25 |
| 2024 | 11 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 184 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assiut University | 5 |
| Universidad Complutense de Madrid | 5 |
| Laboratoires URGO | 4 |
| Unity Health Toronto | 4 |
| Hadassah Medical Organization | 3 |
| Hospices Civils de Lyon | 3 |
| Jie Shen | 3 |
| U.S. Wound Registry | 3 |
| University Health Network, Toronto | 3 |
| Affiliated Hospital of Nantong University | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetic Foot | 184 |
| Diabetes Mellitus | 32 |
| Varicose Ulcer | 12 |
| Peripheral Vascular Diseases | 10 |
| Foot Ulcer | 8 |
| Chronic Limb-Threatening Ischemia | 7 |
| Pressure Ulcer | 7 |
| Wounds and Injuries | 7 |
| Diabetic Neuropathies | 6 |
| Diabetes Complications | 5 |
Trials
Showing 51 to 75 of 184. Each trial links to its page on Pharma Observatory.
84 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.